Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-17

Clinical Trial Update: FMT in Checkpoint Inhibitor-mediated Diarrhea and Colitis [NA]

View source ↗

Summary

Clinical trial update on fecal microbiota transplantation to treat checkpoint inhibitor–induced diarrhea and colitis; currently RECRUITING at the University of …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Aarhus | Conditions: Diarrhea, Colitis | NA | Status: RECRUITING